ACG Wealth’s BioTelemetry, Inc. BEAT Stock Holding History

ACG Wealth’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,929	Closed	-$211K	–	354
2020 Q4	$211K	Buy	+2,929	New	+$153K	0.03%	295

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

ACG Wealth's BEAT Position: Q1 2021 in Review

ACG Wealth sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 2,929 shares — an estimated $211K sold.

ACG Wealth first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $211K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

ACG Wealth reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
ACG Wealth sold 2,929 BioTelemetry, Inc. shares in Q1 2021, an estimated $211K.
ACG Wealth first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
ACG Wealth's BioTelemetry, Inc. position peaked at $211K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on ACG Wealth's 13F filing for Q1 2021, filed 3 May 2021.